Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Annals of Hematology
|
February 26, 1999
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1
M T Petrucci, M R Ricciardi, C Ariola, et al.
Cytokines and Molecular Therapy
|
December 1, 1996
Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis
M T Petrucci, L De Felice, M R Ricciardi, et al.
Leukemia & Lymphoma
|
June 28, 2001
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells
M T Petrucci, M R Ricciardi, C Gregorj, et al.
Current Pharmaceutical Design
|
August 17, 2005
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects
M Milella, C M Precupanu, C Gregorj, et al.
Blood Cancer Journal
|
March 18, 2017
Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment
X Leleu, C Kyriakou, I Vande Broek, et al.
Bone Marrow Transplantation
|
December 7, 2000
High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
G Meloni, S Capria, S Trasarti, et al.
Leukemia Research
|
December 1, 1995
Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia
A Tafuri, A Sommaggio, L Burba, et al.
CNS & Neurological Disorders Drug Targets
|
January 11, 2012
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy
A Truini, A Biasiotta, G Di Stefano, et al.
Cytokines and Molecular Therapy
|
December 1, 1995
Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen
A Tafuri, L De Felice, M T Petrucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1995
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
P Galieni, M Cavo, G Avvisati, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Annals of Hematology
|
February 26, 1999
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1
M T Petrucci, M R Ricciardi, C Ariola, et al.
Cytokines and Molecular Therapy
|
December 1, 1996
Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis
M T Petrucci, L De Felice, M R Ricciardi, et al.
Leukemia & Lymphoma
|
June 28, 2001
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells
M T Petrucci, M R Ricciardi, C Gregorj, et al.
Current Pharmaceutical Design
|
August 17, 2005
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects
M Milella, C M Precupanu, C Gregorj, et al.
Blood Cancer Journal
|
March 18, 2017
Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment
X Leleu, C Kyriakou, I Vande Broek, et al.
Bone Marrow Transplantation
|
December 7, 2000
High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
G Meloni, S Capria, S Trasarti, et al.
Leukemia Research
|
December 1, 1995
Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia
A Tafuri, A Sommaggio, L Burba, et al.
CNS & Neurological Disorders Drug Targets
|
January 11, 2012
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy
A Truini, A Biasiotta, G Di Stefano, et al.
Cytokines and Molecular Therapy
|
December 1, 1995
Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen
A Tafuri, L De Felice, M T Petrucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1995
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
P Galieni, M Cavo, G Avvisati, et al.
Page
of 6